Nivolumab and Pembrolizumab for Non-Small Cell Lung Cancer von Morgensztern, Daniel, Herbst, Roy S

Volltext

Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451 von Owonikoko, Taofeek K., Park, Keunchil, Govindan, Ramaswamy, Ready, Neal, Reck, Martin, Peters, Solange, Dakhil, Shaker R., Navarro, Alejandro, Rodriguez-Cid, Jeronimo, Schenker, Michael, Lee, Jong-Seok, Gutierrez, Vanesa, Percent, Ivor, Morgensztern, Daniel, Barrios, Carlos H., Greillier, Laurent, Baka, Sofia, Patel, Miten, Lin, Wen Hong, Selvaggi, Giovanni, Baudelet, Christine, Baden, Jonathan, Pandya, Dimple, Doshi, Parul, Kim, Hye Ryun

Volltext

The expanding role of circulating tumor DNA in resectable non–small cell lung cancer von Morgensztern, Daniel

Volltext

Changing Epidemiology of Small-Cell Lung Cancer in the United States Over the Last 30 Years: Analysis of the Surveillance, Epidemiologic, and End Results Database von GOVINDAN, Ramaswamy, PAGE, Nathan, MORGENSZTERN, Daniel, READ, William, TIERNEY, Ryan, VLAHIOTIS, Anna, SPITZNAGEL, Edward L, PICCIRILLO, Jay

Volltext

PI3K/Akt/mTOR pathway as a target for cancer therapy von Morgensztern, Daniel, McLeod, Howard L

Volltext

A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105 von Drilon, Alexander, Fu, Siqing, Patel, Manish R, Fakih, Marwan, Wang, Ding, Olszanski, Anthony J, Morgensztern, Daniel, Liu, Stephen V, Cho, Byoung Chul, Bazhenova, Lyudmila, Rodriguez, Cristina P, Doebele, Robert C, Wozniak, Antoinette, Reckamp, Karen L, Seery, Tara, Nikolinakos, Petros, Hu, Zheyi, Oliver, Jennifer W, Trone, Denise, McArthur, Katherine, Patel, Rupal, Multani, Pratik S, Ahn, Myung-Ju

Volltext

Circulating Tumor DNA Profiling in Small-Cell Lung Cancer Identifies Potentially Targetable Alterations von Devarakonda, Siddhartha, Sankararaman, Sumithra, Herzog, Brett H, Gold, Kathryn A, Waqar, Saiama N, Ward, Jeffrey P, Raymond, Victoria M, Lanman, Richard B, Chaudhuri, Aadel A, Owonikoko, Taofeek K, Li, Bob T, Poirier, John T, Rudin, Charles M, Govindan, Ramaswamy, Morgensztern, Daniel

Volltext

Distinctive Characteristics of Non-small Cell Lung Cancer (NSCLC) in the Young: A Surveillance, Epidemiology, and End Results (SEER) Analysis von Subramanian, Janakiraman, Morgensztern, Daniel, Goodgame, Boone, Baggstrom, Maria Q., Gao, Feng, Piccirillo, Jay, Govindan, Ramaswamy

Volltext

The biology and management of non-small cell lung cancer von Herbst, Roy S., Morgensztern, Daniel, Boshoff, Chris

Volltext

Results of a phase 1 study of SRF388, a first-in-human, first-in-class, high-affinity anti-IL-27 antibody in advanced solid tumors von Patnaik, Amita, Morgensztern, Daniel, Mantia, Charlene, Tannir, Nizar M., Harshman, Lauren C, Hill, Jonathan, White, Kerry, Chung, Jou-Ku, Bowers, Beth, Sciaranghella, Gaia, Lee, Benjamin, Choueiri, Toni K., Smith, Lon S., Naing, Aung

Volltext

Incidence and risk factors for bone metastases at presentation in solid tumors von Knapp, Brendan J, Cittolin-Santos, Giordano F, Flanagan, Mary E, Grandhi, Nikhil, Gao, Feng, Samson, Pamela P, Govindan, Ramaswamy, Morgensztern, Daniel

Volltext

Effect of metastatic site on survival in patients with neuroendocrine neoplasms (NENs). An analysis of SEER data from 2010 to 2014 von Trikalinos, Nikolaos A., Tan, Benjamin R., Amin, Manik, Liu, Jingxia, Govindan, Ramaswamy, Morgensztern, Daniel

Volltext

KEYNOTE-042 and the role for single agent pembrolizumab in patients with PD-L1 tumor proportion score 1–49 von Morgensztern, Daniel

Volltext

Exploring the Feasibility of Utilizing Limited Gene Panel Circulating Tumor DNA Clearance as a Biomarker in Patients With Locally Advanced Non-Small Cell Lung Cancer von Knapp, Brendan, Mezquita, Laura, Devarakonda, Siddhartha, Aldea, Mihaela, Waqar, Saiama N, Pepin, Kym, Ward, Jeffrey P, Botticella, Angela, Howarth, Karen, Knape, Charlene, Morris, Clive, Govindan, Ramaswamy, Besse, Benjamin, Morgensztern, Daniel

Volltext

Role for Surgical Resection in the Multidisciplinary Treatment of Stage IIIB Non–Small Cell Lung Cancer von Bott, Matthew J., MD, Patel, Aalok P., MD, Crabtree, Traves D., MD, Morgensztern, Daniel, MD, Robinson, Clifford G., MD, Colditz, Graham A., MD, Waqar, Saiama, MD, Kreisel, Daniel, MD, PhD, Krupnicka, A. Sasha, MD, Patterson, G. Alexander, MD, Broderick, Stephen, MD, Meyers, Bryan F., MD, Puri, Varun, MD

Volltext

Chemotherapy for Advanced-Stage Non-Small Cell Lung Cancer von Du, Lingling, Morgensztern, Daniel

Volltext

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma von Govindan, Ramaswamy, Aggarwal, Charu, Antonia, Scott J, Davies, Marianne, Dubinett, Steven M, Ferris, Andrea, Forde, Patrick M, Garon, Edward B, Goldberg, Sarah B, Hassan, Raffit, Hellmann, Matthew D, Hirsch, Fred R, Johnson, Melissa L, Malik, Shakun, Morgensztern, Daniel, Neal, Joel W, Patel, Jyoti D, Rimm, David L, Sagorsky, Sarah, Schwartz, Lawrence H, Sepesi, Boris, Herbst, Roy S

Volltext

Treating Locally Advanced Disease: An Analysis of Very Large, Hilar Lymph Node Positive Non-Small Cell Lung Cancer Using the National Cancer Data Base von Moreno, Amy C., BA, Morgensztern, Daniel, MD, Boffa, Daniel J., MD, Decker, Roy H., MD, PhD, Yu, James B., MD, Detterbeck, Frank C., MD, Wang, Zuoheng, PhD, Rose, Michal G., MD, Kim, Anthony W., MD

Volltext

nab-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+) von Morgensztern, Daniel, Dols, Manuel Cobo, Aix, Santiago Ponce, Postmus, Pieter E., Bennouna, Jaafar, Fischer, Jurgen R., Juan-Vidal, Oscar, Stewart, David J., Ardizzoni, Andrea, Bhore, Rafia, Wolfsteiner, Marianne, Reck, Martin, Talbot, Denis, Govindan, Ramaswamy, Ong, Teng Jin

Volltext

Barriers to Enrollment in Non-small Cell Lung Cancer Therapeutic Clinical Trials von Baggstrom, Maria Q., Waqar, Saiama N., Sezhiyan, Ananth K., Gilstrap, Eve, Gao, Feng, Morgensztern, Daniel, Govindan, Ramaswamy

Volltext